Cellexus Biosystems incorporates wholly owned
subsidiary in the United States of America
27th February 2007
Cellexus
Biosystems PLC (CBIO:
PLUS Markets) of Cambridgeshire, United Kingdom, is pleased to announce
the incorporation of its wholly owned subsidiary in the USA.
Cellexus
Biosystems Inc was incorporated in
the State of Delaware and will have its registered office in the State of
New Jersey.
“We are moving rapidly to establish a permanent presence in the US as we
continue to make in-roads into the US-biopharmaceutical industry with our
ground-breaking products” stated Dr Kevin Auton
(CEO). “We aim to open a
Customer Support Centre in the State of New Jersey in the immediate
future, to provide pre- and post-sales support for our existing and future
customers, as well as our sales channels, as these are implemented.”
ENDS
Notes and contact details:
ABOUT CELLEXUS
BIOSYSTEMS PLC
Cellexus
Biosystems has developed a range of
value-added disposables to help researchers in the biopharmaceutical
industry and academia develop new biopharmaceutical products from cell
lines. Biopharmaceuticals are the new breed of medicines, generated by
culturing cells in bioreactors. These medicines are often proteins, such
as antibodies or can be vaccines. The potential of future medical
treatments offered by stem cell research would also fall within this
category. Sales of biopharmaceuticals reached US$60 billion in 2005 and
are growing at 20% per annum.
The Company has already developed a family of products. Three products
have been developed all based around the core technology - the
CellexusBagTM – and are marketed
under the name: CellMaker
LiteTM. These products
potentially offer significant technological improvements for cell culture
and cell growth in the developing disposables market.
Unlike competitive products, the CellexusBag
products do not need to be stirred, shaken, rocked or rolled, which means
the equipment used to manage the cell culture process is very simple and
inexpensive. A patent application protecting the Company’s intellectual
property was filed in December 2005.
High resolution photographs can be downloaded from:
http://www.cellexusbiosystems.com/index_files/CellexusBiosystemsMediaResources.htm
CELLEXUS
BIOSYSTEMS PLC:
Cellexus
Biosystems PLC
1010 Cambourne Business Park
Cambourne, Cambridge
CB3 6DP, United Kingdom
Dr Kevin Auton,
CEO
Tel: +44 1354 657 407
Fax: +44 870 135 5536
Email: kevin.auton@cellexusbiosystems.com
www.cellexusbiosystems.com
CORPORATE ADVISER:
JM Finn & Co
Salisbury House, London Wall, London EC2M 5TA
Mr Clive Carver
Tel: +44 207 628 9688
Email: clive.carver@jmfinn.com
www.jmfinn.com
MEDIA CONTACT FOR CELLEXUS BIOSYSTEMS PLC
Not This Limited
Tel: +44 1480 352 821
Email:
info@notthislimited.co.uk
www.notthislimited.co.uk
